NEOADJUVANT
Clinical trials for NEOADJUVANT explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT trials appear
Sign up with your email to follow new studies for NEOADJUVANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink ovarian tumors before surgery
Disease control Recruiting nowThis study tests whether giving the targeted drug mirvetuximab soravtansine together with standard chemotherapy (carboplatin) before surgery can shrink advanced ovarian, fallopian tube, or peritoneal cancers that have a specific protein (FRα). About 140 adults with stage III or I…
Matched conditions: NEOADJUVANT
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail aims to stop kidney cancer comeback
Disease control Recruiting nowThis Phase 3 trial tests whether giving a combination of axitinib (a targeted therapy) and toripalimab (an immunotherapy) before surgery can help prevent kidney cancer from returning in high-risk patients. About 298 participants will either receive the drug combo followed by surg…
Matched conditions: NEOADJUVANT
Phase: PHASE3 • Sponsor: ZHOU FANGJIAN • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug combo shows promise in shrinking esophageal tumors before surgery
Disease control Recruiting nowThis study tests a combination of an immunotherapy drug (ivonescimab) with two chemotherapy drugs before surgery for people with a certain type of advanced esophageal cancer. The goal is to see if this approach can shrink tumors enough to improve long-term outcomes. About 45 adul…
Matched conditions: NEOADJUVANT
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC